MedPath

Mother-Infant Dialectical Behaviour Therapy (MI-DBT) for mothers with borderline personality disorder

Not Applicable
Recruiting
Conditions
Borderline personality disorder (BPD)
Mental Health - Psychosis and personality disorders
Registration Number
ACTRN12624000225516
Lead Sponsor
Helen Mayo House, Women's and Children's Health Network
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
200
Inclusion Criteria

Inclusion criteria are women who have an infant under three years of age who are referred for MI-DBT therapy and have been assessed by mental health clinicians and either diagnosed with BPD or have traits of BPD as defined by the DSM-5. The referral pathway for entry into the MI-DBT group therapy program is either via recommendation from a consulting psychiatrist following a mother’s inpatient stay at Helen Mayo House, or referral from a community mental health provider.

Exclusion Criteria

Exclusion criteria include illiteracy, current uncontrolled psychosis, substance dependence that requires detox, and/or significant cognitive impairment. These criteria are on the basis that individuals need to have a sufficient level of functioning to be able to participate in therapy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Participants change in BPD symptom severity[The Borderline Symptom List-23 (BSL-23) At baseline, post MI-DBT (week 24 of MI-DBT treatment; primary endpoint), 12-month follow-up, and 36-month follow-up.];Participants change in mother-infant interaction [The Nursing Child Assessment Satellite Training (NCAST) Parent-Child Interaction (PCI) Teaching Scale At baseline and post MI-DBT (week 24 of MI-DBT treatment).];Participants qualitative evaluation of the therapies (including treatment feasibility)[Semi-structured interview At baseline, post MI-DBT (week 24 of MI-DBT treatment; primary endpoint), 12-month follow-up, and 36-month follow-up.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath